ID   TK-1 [Human myeloid leukemia]
AC   CVCL_B326
DR   Wikidata; Q54972518
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3457771;
CC   Population: Japanese.
CC   Doubling time: 36-48 hours (PubMed=3457771).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
CH   CVCL_B331 ! TK-1B
CH   CVCL_B327 ! TK-1D
//
RX   PubMed=3457771; DOI=10.1002/ijc.2910370518;
RA   Ohno, Hitoshi
RA   Doi, Shoichi
RA   Fukuhara, Shiro
RA   Yamasowa, Michihiko
RA   Kannagi, Mari
RA   Ishikura, Hiroto
RA   Nishikori, Masaru
RA   Uchino, Haruto
RT   "Establishment of a new myeloid leukemia cell line (TK-1), and
RT   isolation of cells having a translocation involving a band 17q23.";
RL   Int. J. Cancer 37:761-767(1986).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//